# Council regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished Pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical, Annex III: Additions to the list of prefixes and suffixes which, in combination with the INNs, describe salts, esters or hydrates of INNs

Extent: E+W+S+N.I.

N-acetylglycinate
acistrate
acoxil
amsonate
benzathine
bezomil
buciclate
bunapsilate
buteprate
butyl ester
carbesilate
p-chlorobenzenesulfonate
p-chlorobenzenesulphonate
ciclotate
cipionate
closilate
closylate
crobefate
cromacate
cromesilate
cyclopentanepropionate
cyclotate
cypionate
dapropate
deanil
decil
dibudinate
dibunate
diethanolamine
digolil
N,N-dimethyl-beta-alanine
diolamine
docosil
dofosfate
edamine
edisylate
epolamine
erbumine
etabonate
ethanolamine
ethylenediamine
farnesil
fendizoate
fostedate
hibenzate
hybenzate
hyclate
o-(4-hydroxybenzoyl)benzoate
isocaproate
lauril
laurilsulfate
laurilsulphate
lauryl
laurylsulfate
laurylsulphate
megallate
metembonate
4-methylbicyclo[2.2.2]oct-2-ene-l-carboxylate
mofetil
octil
olamine
oxoglurate
pendetide
pivoxetil
proxetil
l-pyrrolidineethanol
sodium lauril sulfate
sodium lauril sulphate
sodium lauryl sulfate
sodium lauryl sulphate
steaglate
tenoate
teprosilate
tetradecyl hydrogen phosphate
tofesilate
triclofenate
triethanolamine
triflutate
trolamine
trometamol
tromethamine
troxundate
xinafoate

---
Source: https://www.legislation.gov.uk/eur/1997/467/annex/III (the official version)
Page: https://openlegislation.uk/eu-regulation-1997-467/annex-III
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.